AURORA CANNABIS INC. will hold a virtual special meeting on December 23, 2026, with November 18, 2026 serving as the record date for notice, voting and beneficial ownership determination.
ACB · Aurora Cannabis Inc
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Close
- $4.26
- Open
- $4.40
- Day range
- $4.26–4.43
- 52-week closing range
- $2.58–5.57
- Average volume, 30 days
- 1.5M
- Short interest
- 8.4M · 12.8% of shares · 12.8 days
- Short volume, last session
- 49%
- Last earnings
- Nov 12, 2026
- Price history
- Jan 2020 to Nov 2026
Up next
Latest documents
Organigram Global Inc. will acquire all issued and outstanding Aurora Cannabis Inc. shares for C$7.80 cash, 5.8626 Organigram shares, or C$3.75 cash plus 3.0431 shares, subject to proration. The transaction is expected to close in January 2027.
Aurora Cannabis Inc. reported net revenue of 86,021 versus 78,809 and net loss of 21,050 versus 53,049 for the three months ended September 30, 2026 and 2025, in thousands of Canadian dollars.
Organigram Global Inc. agreed to acquire Aurora Cannabis Inc. for C$7.80 in total consideration per share, valuing Aurora at approximately C$561 million; Aurora shareholders are expected to hold approximately 35% of Organigram’s economic interest and 42% of its voting interest.
Aurora Cannabis Inc. agreed to sell all outstanding shares to Organigram for C$7.80 per share, valuing the company at approximately C$561 million on a fully diluted basis and representing a 93% premium; completion is expected in January 2027.
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ACB
this stock
Aurora Cannabis Inc
|
$280.07M | +0.9% | — | — | 12.8% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$68.40B | +37.3% | — | — | 0.1% |
|
GALDY
Galderma Group AG
|
$50.89B | +5.3% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$44.97B | +23.5% | +4.3% | 87.6 | 2.4% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
$40.66B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 9, 2026
- This year
- 48
AURORA CANNABIS INC. will hold a virtual special meeting on December 23, 2026, with November 18, 2026 serving as the record date for notice, voting and beneficial ownership determination.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ACB | -14.6% | +7.3% | +17.0% | +4.9% | +1.0% |
| SPY | -5.5% | -6.3% | -5.6% | -5.3% | +5.0% |
| vs SPY | -9.2% | +13.6% | +22.7% | +10.2% | -4.0% |